当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析

尔康制药

(300267)

  

流通市值:54.05亿  总市值:78.38亿
流通股本:14.22亿   总股本:20.63亿

尔康制药(300267)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.27亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益441203.98万元,未分配利润120566.67万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产520267.30万元,负债79063.32万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,006,423,651.81681,881,688.38353,547,866.171,139,612,276.29
营业总成本985,154,942.51656,655,615.53338,072,474.371,213,768,146.03
其他经营收益
营业利润34,268,975.5232,112,145.2626,228,298.64-370,608,077.22
利润总额30,750,162.6832,053,479.3826,586,884.54-388,117,806.27
净利润27,110,714.4528,810,557.5423,942,043.19-392,626,872.67
每股收益
其他综合收益-17,720,724.55-15,845,203.45-11,550,621.21-15,464,320.82
综合收益总额9,389,989.912,965,354.0912,391,421.98-408,091,193.49
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计1,774,063,309.931,615,999,351.771,676,715,416.551,717,081,656.36
非流动资产:
非流动资产合计3,428,609,658.33,433,891,528.963,447,614,260.363,482,652,834.83
资产总计5,202,672,968.235,049,890,880.735,124,329,676.915,199,734,491.19
流动负债:
流动负债合计692,305,389.92533,867,935.14618,820,138.93705,342,064.26
非流动负债:
非流动负债合计98,327,822.11100,574,984.1290,750,430.5192,198,616.44
负债合计790,633,212.03634,442,919.26709,570,569.44797,540,680.7
所有者权益(或股东权益):
归属于母公司股东权益合计4,469,596,922.144,469,540,895.524,464,244,106.54,447,425,532.36
股东权益合计4,412,039,756.24,415,447,961.474,414,759,107.474,402,193,810.49
负债和股东权益合计5,202,672,968.235,049,890,880.735,124,329,676.915,199,734,491.19
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,200,091,914.04805,749,020.76344,190,570.111,252,255,073.92
经营活动现金流出小计988,407,066.69759,906,773.23348,339,077.011,085,563,367
经营活动产生的现金流量净额211,684,847.3545,842,247.53-4,148,506.9166,691,706.92
投资活动产生的现金流量:
投资活动现金流入小计744,694,174.37344,066,779.96103,008,332.8212,514,361.74
投资活动现金流出小计932,779,667.07449,007,926.1929,637,797.69534,669,337.8
投资活动产生的现金流量净额-188,085,492.7-104,941,146.2373,370,535.11-322,154,976.06
筹资活动产生的现金流量:
筹资活动现金流入小计692,587,821410,000,000170,000,000796,080,000
筹资活动现金流出小计725,728,061.56475,915,412.21230,554,397.7654,935,595.34
筹资活动产生的现金流量净额-33,140,240.56-65,915,412.21-60,554,397.7141,144,404.66
汇率变动对现金及现金等价物的影响-2,347,103.42-1,555,462.31-1,106,513.25-6,409,837.1
现金及现金等价物净增加额-11,887,989.33-126,569,773.227,561,117.26-20,728,701.58
期末现金及现金等价物余额478,021,035.45363,339,251.56497,470,142.04489,909,024.78
补充资料:
现金及现金等价物的净增加额--126,569,773.22--20,728,701.58
TOP↑